546 related articles for article (PubMed ID: 30854687)
1. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
4. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
5. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
6. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
[TBL] [Abstract][Full Text] [Related]
7. Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation.
Yin W; Han J; Zhang Z; Han Z; Wang S
Sci Rep; 2018 Apr; 8(1):6265. PubMed ID: 29674691
[TBL] [Abstract][Full Text] [Related]
8. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
Nie Y; Zhang D; Qian F; Wu Y
Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
[TBL] [Abstract][Full Text] [Related]
9. Baicalin alleviates bleomycin‑induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K/AKT signaling pathway.
Zhao H; Li C; Li L; Liu J; Gao Y; Mu K; Chen D; Lu A; Ren Y; Li Z
Mol Med Rep; 2020 Jun; 21(6):2321-2334. PubMed ID: 32323806
[TBL] [Abstract][Full Text] [Related]
10. Aucubin Alleviates Bleomycin-Induced Pulmonary Fibrosis in a Mouse Model.
Zhou Y; Li P; Duan JX; Liu T; Guan XX; Mei WX; Liu YP; Sun GY; Wan L; Zhong WJ; Ouyang DS; Guan CX
Inflammation; 2017 Dec; 40(6):2062-2073. PubMed ID: 28785877
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
12. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
15. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
16. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of α-SMA by the ectodomain of FGFR2c attenuates lung fibrosis.
Ju W; Zhihong Y; Zhiyou Z; Qin H; Dingding W; Li S; Baowei Z; Xing W; Ying H; An H
Mol Med; 2012 Sep; 18(1):992-1002. PubMed ID: 22451267
[TBL] [Abstract][Full Text] [Related]
18. P120-catenin regulates pulmonary fibrosis and TGF-β induced lung fibroblast differentiation.
Zhang Y; Jiao H; Wu Y; Sun X
Life Sci; 2019 Aug; 230():35-44. PubMed ID: 31125560
[TBL] [Abstract][Full Text] [Related]
19. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
Li A; Xiao X; Feng ZL; Chen X; Liu LJ; Lin LG; Lu JJ; Zhang LL
Toxicol Appl Pharmacol; 2020 Jan; 389():114882. PubMed ID: 31953203
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of Ramelteon on bleomycin-induced pulmonary fibrosis in mice.
Zhang L; Cheng T; Chen W; Zhong C; Li M; Xie Y; Deng Q; Wang H; Yang Z; Ju J; Liang H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4153-4163. PubMed ID: 38032492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
